Showing results (201-210 of 278) with videos related to

Sort By:
Pageof 28
Circulation. Heart Failure|January 20, 2025
Transferrin Saturation, Serum Iron, and Ferritin in Heart Failure: Prognostic Significance and Proteomic AssociationsSushrima Gan, Joe David Azzo, Lei Zhao, et al.
Mayo Clinic Proceedings|July 6, 2019
Characterization of the Obese Phenotype of Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary StudyYogesh N V Reddy, Gregory D Lewis, Sanjiv J Shah, et al.
Frontiers in Physiology|May 9, 2022
Advances in Our Clinical Understanding of Autonomic Regulation Therapy Using Vagal Nerve Stimulation in Patients Living With Heart FailureMarvin A Konstam, Douglas L Mann, John James E Udelson, et al.
JACC. Heart Failure|July 6, 2024
Optimizing Triage of Ambulatory Patients With Advanced Heart Failure: 2-Year Outcomes From REVIVALKeith D Aaronson, Garrick C Stewart, Lynne W Stevenson, et al.
European Journal of Clinical Investigation|February 26, 2019
Pulse pressure and prognosis in patients with heart failure with reduced ejection fractionNeeraj Shah, Min Qian, Marco R Di Tullio, et al.
Journal of Cardiac Failure|December 28, 2021
Frailty Measures of Patient-reported Activity and Fatigue May Predict 1-year Outcomes in Ambulatory Advanced Heart Failure: A Report From the REVIVAL RegistryAnuradha Lala, Palak Shah, Shokoufeh Khalatbari, et al.
JAMA|August 3, 2016
Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical TrialKenneth B Margulies, Adrian F Hernandez, Margaret M Redfield, et al.
Circulation. Heart Failure|May 1, 2023
Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI TrialKarola S Jering, Brian L Claggett, Marc A Pfeffer, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 5, 2019
Registry Evaluation of Vital Information for VADs in Ambulatory Life (REVIVAL): Rationale, design, baseline characteristics, and inclusion criteria performanceKeith D Aaronson, Garrick C Stewart, Francis D Pagani, et al.
European Heart Journal|June 18, 2015
A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial)Stefan D Anker, Andrew J S Coats, Gabriel Cristian, et al.
Pageof 28